ArticleMedComm2024

Cancer-associated fibroblast-derived colony-stimulating factor 2 confers acquired osimertinib resistance in lung adenocarcinoma via promoting ribosome biosynthesis.

Yutang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.